Role of transforming growth factor beta in human cancer

被引:549
作者
Elliott, RL
Blobe, GC
机构
[1] Duke Univ, Med Ctr, Dept Med & Pharmacol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27710 USA
关键词
D O I
10.1200/JCO.2005.02.047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor beta (TGF-beta) is a ubiquitous and essential regulator of cellular and physiologic processes including proliferation, differentiation, migration, cell survival, angiogenesis, and immunosurveillance. Alterations in the TGF-beta signaling pathway, including mutation or deletion of members of the signaling pathway and resistance to TGF-beta mediated inhibition of proliferation are frequently observed in human cancers. Although these alterations define a tumor suppressor role for the TGF-beta pathway in human cancer, TGF-beta also mediates tumor-promoting effects, either through differential effects on tumor and stromal cells or through a fundamental alteration in the TGF-beta responsiveness of the tumor cells themselves. TGF-beta and members of the TGF-beta signaling pathway are being evaluated as prognostic or predictive markers for cancer patients. Ongoing advances in understanding the TGF-beta signaling pathway will enable targeting of this pathway for the chemoprevention and treatment of human cancers. (c) 2005 by American Society of Clinical Oncology.
引用
收藏
页码:2078 / 2093
页数:16
相关论文
共 232 条
[1]   Inhibition of farnesyltransferase increases TGFβ type II receptor expression and enhances the responsiveness of human cancer cells to TGFβ [J].
Adnane, J ;
Bizouarn, FA ;
Chen, Z ;
Ohkanda, J ;
Hamilton, AD ;
Munoz-Antonia, T ;
Sebti, SM .
ONCOGENE, 2000, 19 (48) :5525-5533
[2]   OVEREXPRESSION OF THE C-MYC ONCOPROTEIN BLOCKS THE GROWTH-INHIBITORY RESPONSE BUT IS REQUIRED FOR THE MITOGENIC EFFECTS OF TRANSFORMING GROWTH-FACTOR-BETA-1 [J].
ALEXANDROW, MG ;
KAWABATA, M ;
AAKRE, M ;
MOSES, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3239-3243
[3]  
Ananth S, 1999, CANCER RES, V59, P2210
[4]   MEMBRANE-ANCHORED AND SOLUBLE FORMS OF BETAGLYCAN, A POLYMORPHIC PROTEOGLYCAN THAT BINDS TRANSFORMING GROWTH FACTOR-BETA [J].
ANDRES, JL ;
STANLEY, K ;
CHEIFETZ, S ;
MASSAGUE, J .
JOURNAL OF CELL BIOLOGY, 1989, 109 (06) :3137-3145
[5]   Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation [J].
Anscher, MS ;
Marks, LB ;
Shafman, TD ;
Clough, R ;
Huang, H ;
Tisch, A ;
Munley, M ;
Herndon, JE ;
Garst, J ;
Crawford, J ;
Jirtle, RL .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) :3758-3765
[6]   TRANSFORMING GROWTH-FACTOR-BETA AS A PREDICTOR OF LIVER AND LUNG FIBROSIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED BREAST-CANCER [J].
ANSCHER, MS ;
PETERS, WP ;
REISENBICHLER, H ;
PETROS, WP ;
JIRTLE, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1592-1598
[7]   TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: Transcriptional activation of I kappa B alpha [J].
Arsura, M ;
Wu, M ;
Sonenshein, GE .
IMMUNITY, 1996, 5 (01) :31-40
[8]  
Arsura M, 1997, CELL GROWTH DIFFER, V8, P1049
[9]   Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-beta through stress-activated protein kinase c-Jun N-terminal kinase (SAPK/JNK) signaling pathway [J].
Atfi, A ;
Buisine, M ;
Mazars, A ;
Gespach, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :24731-24734
[10]   Signal transduction by the TGF-β superfamily [J].
Attisano, L ;
Wrana, JL .
SCIENCE, 2002, 296 (5573) :1646-1647